Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research ...(target _new http://www.canopusbiopharma....),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
Date:6/18/2008
target="_new">http://www.canopusbiopharma.com.
'/>"/>
| SOURCE Canopus BioPharma, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
Breaking Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4Monogram Energy Inc Acquires Triad Therapeutics Inc 61747 1Monogram Energy Inc Acquires Triad Therapeutics Inc 61747 2AUDIO from Medialink and Ortho McNeil Janssen Pharmaceuticals Inc 3A Getting Ready for Cold and Flu Season 6416 1Scripps research scientists find new link between insulin and core body temperature 10816 1Scripps research scientists find new link between insulin and core body temperature 10816 2Scripps research scientists find new link between insulin and core body temperature 10816 3Scripps research scientists find new link between insulin and core body temperature 10816 4
Other Medicine Technology:Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 2Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 3Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 4Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 5Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 6Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 7Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours 2
Breaking Medicine News(10 mins):Health News:You Never Get a Second Chance to Make a First Impression: High-Definition for the Web 2Health News:Dr. 90210 Rhinoplasty Specialist Now Accommodates Both the East and West Coast 2Health News:World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins 2Health News:World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins 3Health News:Perkins: Senate Would Rather Mandate Abortion Funding Than Enact 'Health Care Reform' 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 3Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 4
[0] You Never Get a Second Chance to Make a First Impression: High-Definition for the Web [0] Dr. 90210 Rhinoplasty Specialist Now Accommodates Both the East and West Coast [0] World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins[1] Perkins: Senate Would Rather Mandate Abortion Funding Than Enact 'Health Care Reform'[1] AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding
Other Medicine News:Health News:GetWellNetwork Hits Milestone with Patient Pathways Technology 2Health News:GetWellNetwork Hits Milestone with Patient Pathways Technology 3Health News:American Council on Exercise (ACE) Says Budget-Friendly and Boot Camp-Style Workouts Among Most Popular Fitness Trends in 2009 2Health News:American Council on Exercise (ACE) Says Budget-Friendly and Boot Camp-Style Workouts Among Most Popular Fitness Trends in 2009 3Health News:American Council on Exercise (ACE) Says Budget-Friendly and Boot Camp-Style Workouts Among Most Popular Fitness Trends in 2009 4Health News:Instrumentation Laboratory Announces 'ILeader Panel' of Experts as Part of 50th Anniversary Program 2Health News:Instrumentation Laboratory Announces 'ILeader Panel' of Experts as Part of 50th Anniversary Program 3Health News:Instrumentation Laboratory Announces 'ILeader Panel' of Experts as Part of 50th Anniversary Program 4Health News:PatentStorm Releases U.S. Patent Applications and Other Features 2Health News:CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb 2Health News:CSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to Climb 3Health News:Top Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia 2Health News:Top Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia 3
GetWellNetwork Hits Milestone with Patient Pathways TechnologyAmerican Council on Exercise (ACE) Says Budget-Friendly and Boot Camp-Style Workouts Among Most Popular Fitness Trends in 2009Instrumentation Laboratory Announces 'ILeader Panel' of Experts as Part of 50th Anniversary ProgramPatentStorm Releases U.S. Patent Applications and Other FeaturesCSC Survey Reveals Hospitals Find Current Recession Far Worse Than Last Downturn; Emergency Visits to ClimbTop Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |